Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.9 (
ribonuclease
)
6,589
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of ultraviolet irradiation on Escherichia coli 30-S ribosomal subunits were studied. At the doses of radiation used in this work (0-4.5 x 10(5) quanta/30-S subunit), only protein S7 was found to be significantly crosslinked to the 16-S RNA. In conditions where 25% of the protein was covalently crosslinked, the ability of the irradiated 30-S subunits to reassociate with 50-S subunits and their activity in polyphenylalanine synthesis decreased strongly. Similar results were obtained by irradiation with a germicide lamp (254 nm) or with a monochromatic ultraviolet light at 248 nm. No additional proteins were crosslinked to the 16-S RNA by irradiating 30-S subunits depleted in protein S1 or 70-S ribosomes. The covalent complex of 16-S RNA and protein S7 was isolated and digested by T1
ribonuclease
. The oligonucleotide remaining attached to the crosslinked protein was characterised as A-C-C-U-C-G [position 1261 - 1266, see the sequence published by
Carbon
et al. (1979) Eur. J. Biochem. 160, 399-410]. Analysis of this fragment suggests that protein S7 was linked to the cytosine at position 1265 in the RNA sequence.
...
PMID:Effect of ultraviolet irradiation on 30-S ribosomal subunits. Identification of the RNA region crosslinked to protein S7. 698 1
This study aimed to screen putative drug targets associated with biofilm formation of multidrug-resistant
Acinetobacter baumannii
and
Pseudomonas areugenosa
and prioritize carbon nano-fullerene as potential lead molecule by structure-based virtual screening. Based on the functional role, 36 and 83 genes that are involved in biofilm formation of
A. baumannii
and
P. areugenosa
respectively were selected and metabolic network was computationally constructed. The genes that lack three-dimensional structures were predicted and validated.
Carbon
nano-fullerene selected as lead molecule and their drug-likeliness and pharmacokinetics properties were computationally predicted. The binding potential of carbon nano-fullerene toward selected drug targets was modeled and compared with the binding of conventional drugs, doripenem, and polymyxin-B with their usual targets. The stabilities of four best-docked complexes were confirmed by molecular dynamic (MD) simulation. This study suggested that selected genes demonstrated relevant interactions in the constructed metabolic pathways.
Carbon
fullerene exhibited significant binding abilities to most of the prioritized targets in comparison with the binding of last-resort antibiotics and their usual target. The four best ligand-receptor interactions predicted by molecular docking revealed that stability throughout MD simulation. Notably, carbon fullerene exhibited profound binding with outer membrane protein (OmpA) and
ribonuclease
-HII (rnhB) of
A. baumannii
and 2-heptyl-4(1H)-quinolone synthase (pqsBC) and chemotaxis protein (wspA) of
P. aeruginosa
. Thus, the current study suggested that carbon fullerene was probably used as potential lead molecules toward selected targets of
A. baumannii
and
P. aeruginosa
and the applied aspects probably scaled up to design promising lead molecules toward these pathogens.Communicated by Ramaswamy H. Sarma.
...
PMID:Carbon fullerene acts as potential lead molecule against prospective molecular targets of biofilm-producing multidrug-resistant
Acinetobacter baumanni
and
Pseudomonas aerugenosa
: computational modeling and MD simulation studies. 3203 42